Inhaled fentanyl aerosol

DRUG3 trials

Sponsors

Lee's Pharmaceutical Limited

Conditions

Breakthrough Cancer PainCancer

Phase 1

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain

Lee's Pharmaceutical LimitedBreakthrough Cancer Pain

Start: 2021-03-15End: 2021-12-21Target: 96Updated: 2021-02-02

A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors

RecruitingNCT06953453

Lee's Pharmaceutical LimitedCancer

Start: 2025-09-23End: 2026-08-20Target: 100Updated: 2025-09-25

Phase 2

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP

CompletedNCT05531422

Lee's Pharmaceutical LimitedBreakthrough Cancer Pain

Start: 2021-10-20End: 2023-04-27Updated: 2024-06-12

Related Papers

Efficacy and safety of fentanyl inhalant for the treatment of breakthrough cancer pain: a multicenter, randomized, double-blind, placebo-controlled trial.

2024-09-07

Inhaled fentanyl aerosol through a drug-device combination for breakthrough cancer pain: A multicenter, randomized, double-blind, placebo-controlled trial.

Journal of Clinical Oncology2024-06-01